| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,759 |
2,348 |
$124K |
| 99215 |
Prolong outpt/office vis |
1,078 |
958 |
$73K |
| 99000 |
|
5,356 |
2,200 |
$51K |
| 94010 |
|
1,847 |
1,637 |
$37K |
| 95012 |
|
1,932 |
1,650 |
$37K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
369 |
316 |
$27K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,587 |
1,599 |
$27K |
| 92081 |
|
1,001 |
948 |
$26K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
228 |
199 |
$25K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
260 |
237 |
$22K |
| 96112 |
|
218 |
202 |
$18K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
449 |
388 |
$17K |
| 36410 |
|
1,965 |
780 |
$16K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
221 |
173 |
$16K |
| 96130 |
|
295 |
262 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
672 |
606 |
$8K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
596 |
276 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
120 |
97 |
$6K |
| 92552 |
|
872 |
841 |
$5K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
94 |
66 |
$5K |
| 80061 |
Lipid panel |
830 |
792 |
$5K |
| 83655 |
|
809 |
770 |
$5K |
| 99417 |
Prolong home eval add 15m |
536 |
465 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
850 |
809 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
520 |
484 |
$4K |
| 99441 |
|
161 |
135 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
167 |
156 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
485 |
466 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
46 |
45 |
$1K |
| 98960 |
|
2,350 |
2,084 |
$1K |
| 99354 |
|
19 |
16 |
$1K |
| 97802 |
|
858 |
830 |
$810.07 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
45 |
44 |
$772.38 |
| 99383 |
|
26 |
26 |
$732.12 |
| 95076 |
|
48 |
47 |
$499.00 |
| 99382 |
|
17 |
17 |
$369.88 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
14 |
14 |
$369.60 |
| 81002 |
|
154 |
142 |
$276.77 |
| 87807 |
|
32 |
26 |
$156.81 |
| 86580 |
|
36 |
35 |
$147.42 |
| 96160 |
|
2,343 |
2,065 |
$146.49 |
| 90461 |
|
129 |
34 |
$114.38 |
| 87430 |
|
13 |
13 |
$108.12 |
| 90688 |
|
49 |
48 |
$90.12 |
| 85014 |
|
57 |
56 |
$67.05 |
| 99078 |
|
25 |
19 |
$42.78 |
| 94760 |
|
917 |
839 |
$12.81 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
16 |
$10.33 |
| 96161 |
|
625 |
553 |
$9.56 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
964 |
864 |
$0.44 |
| 90785 |
|
228 |
199 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,166 |
1,030 |
$0.00 |
| G8539 |
Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment |
371 |
338 |
$0.00 |
| 3725F |
|
642 |
580 |
$0.00 |
| 90863 |
|
139 |
119 |
$0.00 |
| 99051 |
|
43 |
26 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
14 |
12 |
$0.00 |
| 4551F |
|
149 |
142 |
$0.00 |
| 99173 |
|
50 |
50 |
$0.00 |
| 3078F |
|
14 |
12 |
$0.00 |
| 96158 |
|
39 |
36 |
$0.00 |
| 90734 |
|
12 |
12 |
$0.00 |
| 96127 |
|
2,040 |
1,822 |
$0.00 |
| 1111F |
|
1,138 |
1,007 |
$0.00 |
| 99402 |
|
181 |
174 |
$0.00 |
| 92283 |
|
812 |
776 |
$0.00 |
| 4060F |
|
110 |
101 |
$0.00 |
| A9150 |
Non-prescription drugs |
88 |
87 |
$0.00 |
| G8422 |
Bmi not documented, documentation the patient is not eligible for bmi calculation |
14 |
12 |
$0.00 |
| 3700F |
|
110 |
102 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
41 |
40 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
50 |
46 |
$0.00 |
| 0001F |
|
81 |
81 |
$0.00 |
| 85018 |
|
14 |
14 |
$0.00 |
| 96156 |
|
39 |
36 |
$0.00 |
| 3008F |
|
27 |
27 |
$0.00 |